首页> 美国卫生研究院文献>British Journal of Cancer >Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme including efficacy in brain metastases – the UK experience

【2h】

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme including efficacy in brain metastases – the UK experience

机译：拉帕替尼和卡培他滨在拉帕替尼扩展治疗方案中治疗HER2阳性转移性乳腺癌的方法包括脑转移的疗效–英国经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The global lapatinib expanded access programme provided access to lapatinib combined with capecitabine for women with HER2-positive metastatic breast cancer (MBC) who previously received anthracycline, taxane and trastuzumab.

机译：背景：全球拉帕替尼扩展访问计划为先前曾接受蒽环类，紫杉烷和曲妥珠单抗治疗的HER2阳性转移性乳腺癌（MBC）妇女提供了拉帕替尼联合卡培他滨治疗的机会。

著录项

期刊名称 British Journal of Cancer
作者
S Sutherland; S Ashley; D Miles; S Chan; A Wardley; N Davidson; R Bhatti; M Shehata; H Nouras; T Camburn; S R D Johnston;
展开▼
作者单位

展开▼
年(卷),期 2010(102),6
年度 2010
页码 995–1002
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
capecitabine lapatinib Her2+ metastatic breast cancer CNS disease;

机译：卡培他滨;拉帕替尼;Her2 +转移性乳腺癌;中枢神经系统疾病;
入库时间 2022-08-17 13:51:53

相似文献

外文文献
中文文献
专利

1. Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases |[ndash]| the UK experience [J] . S Sutherland, S Ashley, D Miles, British Journal of Cancer . 2010,第6期

机译：拉帕替尼和卡培他滨在拉帕替尼扩大治疗方案中治疗HER2阳性转移性乳腺癌，包括脑转移的疗效| [ndash] |英国的经验
2. A single-institution experience from the Lapatinib Expanded Access Program – effect of lapatinib and capecitabine combination therapy on CNS metastases in patients with ErbB2+ metastatic breast cancer [J] . B.Kaufman, R.Weitzen, A.Goldfarb, European Journal of Cancer Supplements . 2008,第7期

机译：拉帕替尼扩展访问计划的单机构经验–拉帕替尼和卡培他滨联合治疗对ErbB2 +转移性乳腺癌患者中枢神经系统转移的影响
3. A single-institution experience from the Lapatinib Expanded Access Program – effect of lapatinib and capecitabine combination therapy on CNS metastases in patients with ErbB2+ metastatic breast cancer [J] . B.Kaufman, R.Weitzen, A.Goldfarb, European Journal of Cancer Supplements . 2008,第7期

机译：拉帕替尼扩展访问计划的单机构经验–拉帕替尼和卡培他滨联合治疗对ErbB2 +转移性乳腺癌患者中枢神经系统转移的影响
4. Minimally toxic approach for treatment of cutaneous breast cancer metastases: Capecitabine-enhanced photodynamic therapy [C] . Sanjay Anand, Taylor Bullock, Edward V. Maytin Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XXVI . 2017

机译：皮肤癌转移的最小毒性方法：卡培他滨增强的光动力疗法
5. Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea [O] . Jungsil Ro, Sohee Park, Sung- Bae Kim, 2012

机译：拉帕替尼和卡培他滨治疗HER2阳性转移性乳腺癌伴脑转移的乳腺癌患者的临床结局：韩国一项开放标签扩展研究
6. Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience [O] . Sutherland, S, Ashley, S, Miles, D, 2010

机译：拉帕替尼和卡培他滨在拉帕替尼扩展治疗方案中治疗HER2阳性转移性乳腺癌的方法，包括脑转移的疗效–英国经验

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme including efficacy in brain metastases – the UK experience

摘要

著录项

相似文献

相关主题

期刊订阅